← Open Payments lookup

DANIELLE DEJEAN: Open Payments

NPI 1528840345 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$244 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $255 · 2025 $244

Food & beverage: $206Education: $39
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$48
Supernus Pharmaceuticals, Inc.1$45
ABBVIE INC.2$43
Lundbeck LLC1$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Teva Pharmaceuticals USA, Inc.1$17
Currax Pharmaceuticals LLC1$16
Indivior Inc.1$15

Products named: INGREZZA, Qelbree, VRAYLAR, REXULTI, CAPLYTA, UZEDY, ONZETRA XSAIL, SUBLOCADE.

Industry payments across LA — which companies pay providers there.